ES432866A1 - Ophthalmic inserts - Google Patents

Ophthalmic inserts

Info

Publication number
ES432866A1
ES432866A1 ES432866A ES432866A ES432866A1 ES 432866 A1 ES432866 A1 ES 432866A1 ES 432866 A ES432866 A ES 432866A ES 432866 A ES432866 A ES 432866A ES 432866 A1 ES432866 A1 ES 432866A1
Authority
ES
Spain
Prior art keywords
ophthalmic inserts
ophthalmic
eye
reduction
completely
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES432866A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES432866A1 publication Critical patent/ES432866A1/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Ceramic Products (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The ophthalmic inserts containing hydroxypropylcellulose as carrier material are particularly effective because they dissolve slowly but completely in water so that they can be used for the production of suitable compositions for prolonged treatment of the eye with, at the same time, a reduction in the dosage frequency.
ES432866A 1973-12-17 1974-12-12 Ophthalmic inserts Expired ES432866A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42542673A 1973-12-17 1973-12-17
US51932374A 1974-10-31 1974-10-31

Publications (1)

Publication Number Publication Date
ES432866A1 true ES432866A1 (en) 1977-02-16

Family

ID=27026681

Family Applications (2)

Application Number Title Priority Date Filing Date
ES432866A Expired ES432866A1 (en) 1973-12-17 1974-12-12 Ophthalmic inserts
ES451015A Expired ES451015A1 (en) 1973-12-17 1976-08-26 Ophthalmic inserts

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES451015A Expired ES451015A1 (en) 1973-12-17 1976-08-26 Ophthalmic inserts

Country Status (25)

Country Link
JP (1) JPS5636173B2 (en)
AT (1) AT333945B (en)
AU (1) AU509331B2 (en)
CA (1) CA1063022A (en)
CH (2) CH611797A5 (en)
DD (2) DD121643A5 (en)
DE (2) DE2459391C3 (en)
DK (1) DK137946B (en)
EG (1) EG11698A (en)
ES (2) ES432866A1 (en)
FI (1) FI58433C (en)
FR (1) FR2254350B1 (en)
GB (2) GB1485150A (en)
HK (1) HK30880A (en)
HU (1) HU171803B (en)
IE (1) IE40466B1 (en)
IL (1) IL46209A (en)
IT (1) IT1056094B (en)
KE (1) KE3049A (en)
LU (1) LU71490A1 (en)
NL (1) NL167326C (en)
NO (1) NO140489C (en)
PH (2) PH10938A (en)
RO (1) RO63070A (en)
SE (1) SE408014B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076942A (en) * 1975-10-01 1978-02-28 Merck & Co., Inc. Crystalline dipilocarpinium pamoate
US4255415A (en) * 1978-11-22 1981-03-10 Schering Corporation Polyvinyl alcohol ophthalmic gel
JPS5758615A (en) * 1980-09-26 1982-04-08 Nippon Soda Co Ltd Film agnent and its preparation
NZ200429A (en) * 1981-04-30 1984-10-19 Smith & Nephew Ass Applicator for placing pharmaceutically active agent in contact with moist surface,e.g.,eye
DE3376957D1 (en) * 1982-06-24 1988-07-14 Robert Alan Smith Pharmaceutical gel composition
CH667001A5 (en) * 1985-09-03 1988-09-15 Hugo Degen UNDER MATTRESS.
US5036046A (en) * 1988-10-12 1991-07-30 Eye Research Institute Of Retina Foundation, Inc. Method for enhancing healing of corneal endothelial wounds
DE19549506C2 (en) * 1995-03-07 1998-07-30 Richard Prof Dr Sueverkruep Pharmaceutical or diagnostic dosage form, esp. for ophthalmic use
JP5081413B2 (en) * 2005-07-29 2012-11-28 参天製薬株式会社 Non-invasive drug delivery system for posterior ocular tissue using solid composition
WO2011053841A1 (en) * 2009-10-30 2011-05-05 Aton Pharma, Inc. Ocular drug delivery devices
BE1030503B1 (en) 2022-05-06 2023-12-04 Eyed Pharma INSERT FOR THE TREATMENT OF DRY EYE
WO2023214027A1 (en) 2022-05-06 2023-11-09 Eyed Pharma Insert for the treatment of dry eyes
BE1030504B1 (en) 2022-05-06 2023-12-04 Eyed Pharma COMPOSITE INSERT FOR THE TREATMENT OF DRY EYE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875300A (en) * 1972-12-18 1975-04-01 Ortho Pharma Corp Composition for sustained release of a medicament and method of using same

Also Published As

Publication number Publication date
IL46209A (en) 1978-03-10
IE40466L (en) 1975-06-17
HU171803B (en) 1978-03-28
GB1485150A (en) 1977-09-08
DD117349A5 (en) 1976-01-12
DE2459391B2 (en) 1978-02-09
DE2459391A1 (en) 1975-06-19
DE2462081B2 (en) 1979-08-02
DE2462081C3 (en) 1980-04-03
NL167326B (en) 1981-07-16
DD121643A5 (en) 1976-08-12
IT1056094B (en) 1982-01-30
GB1485149A (en) 1977-09-08
IL46209A0 (en) 1975-03-13
ATA996174A (en) 1976-04-15
AU7623574A (en) 1976-06-10
NL167326C (en) 1981-12-16
JPS5636173B2 (en) 1981-08-22
DK137946C (en) 1978-12-11
FI352274A (en) 1975-06-18
NO140489B (en) 1979-06-05
IE40466B1 (en) 1979-06-06
NO140489C (en) 1979-09-19
FI58433C (en) 1981-02-10
HK30880A (en) 1980-06-13
EG11698A (en) 1977-10-31
NO744394L (en) 1975-07-14
SE7415248L (en) 1975-06-18
CH609864A5 (en) 1979-03-30
DK629774A (en) 1975-08-25
FI58433B (en) 1980-10-31
SE408014B (en) 1979-05-14
AT333945B (en) 1976-12-27
FR2254350A1 (en) 1975-07-11
KE3049A (en) 1980-06-06
NL7415883A (en) 1975-06-19
PH10938A (en) 1977-10-05
CA1063022A (en) 1979-09-25
FR2254350B1 (en) 1978-07-21
DE2459391C3 (en) 1978-10-19
CH611797A5 (en) 1979-06-29
DE2462081A1 (en) 1975-11-06
AU509331B2 (en) 1980-05-08
ES451015A1 (en) 1977-08-16
LU71490A1 (en) 1975-08-20
DK137946B (en) 1978-06-12
PH17250A (en) 1984-07-03
RO63070A (en) 1978-06-15
JPS50105814A (en) 1975-08-20

Similar Documents

Publication Publication Date Title
EG11316A (en) Novel triazolyl-o,n-acetals,process for their preparation and their use as fungicides
IL44030A (en) Imidazolymethyl and thiazolylmethyl sulphoxides and process for their preparation
ES451015A1 (en) Ophthalmic inserts
ES425514A1 (en) Coumarin derivatives for the treatment of allergies
ZM16674A1 (en) Treatment process
IL45309A (en) Tetrahydroacridones,process for preparing them and pharmaceutical compositions containing them
ES432848A2 (en) Alkanolamine derivatives
IT1029311B (en) EYE FOR THE DISTRIBUTION OF INULIQUID GAS CONTAINING IMPORTS, IN PARTICULAR WASTE WATERS
ZA744388B (en) Novel 1-ethyl-triazoles, process for their preparation and their use as fungicides
PH12901A (en) Textile after treatment composition
ZA735975B (en) 1-alkylsulphonyl-2-trifluoromethyl-benzimidazoles,process for their production and their use as agents against extoparasites
IL45029A0 (en) Novel benzimidazoles,process for their preparation and their use as fungicides
AU475077B2 (en) Method and compositions for the treatment of dermatomycosis
ES454760A1 (en) Process for manufacturing 2-stilbenyl-1,2,3-triazoles and new 2-stilbenyl-1,2,3-triazoles
ZA742488B (en) Penicillins, processes for their preparation and their use as medicaments
ZA744161B (en) Enzymatic salts, process for their preparation and therapeutical compositions containing them
GB1269969A (en) ETHYL 10 (beta-N-MORPHOLINYLPROPIONYL)-PHENTHIAZINE-2-CARBAMATE AND THE HYDROCHLORIDE THEREOF AND A METHOD FOR PREPARING THE SAME
CA36694S (en) Panty girdle
CA843955A (en) Process for the production of tetrahydro-1, 3,5-thiadiazine-2-thiones and their use as microbicides
CA843956A (en) Process for the production of tetrahydro-1,3,5-thiadiazine-2-thiones and their use as microbicides
ZA731692B (en) Improvements in the treatment of soil
CA806186A (en) Process for preparing tetrahydro-1,3,5-thiadiazine-2-thiones
AU481118B2 (en) Xray contrast agents and process forthe production thereof
AU489487B2 (en) Improvements in or relating tothe treatment of minerals
AU478374B2 (en) Distillation of titanium tetrachloride in solution with selected amines